Trialbee has achieved remarkable success in 2023, with a net revenue increase of 60% to €7.6 million, despite experiencing a loss of €4.7 million, indicating strong market demand and growth potential.
The startup's Honey Platform and Precision Recruitment services utilize data-driven approaches to enhance patient recruitment in clinical trials, providing clients with real-time insights and improving channel efficiency.
With a focus on global expertise, Trialbee's unique combination of transparency and targeted outreach is paving the way for improved clinical trials, ensuring that patients are matched more effectively.
Securing SEK 42.5 million in funding this year underscores investor confidence in Trialbee's innovative approach to streamlining patient recruitment and retention in clinical studies.
Collection
[
|
...
]